Recurrent Clostridioides difficile infection: Recognition, management, prevention

被引:18
|
作者
Tsigrelis, Constantine [1 ,2 ]
机构
[1] Cleveland Clin, Dept Infect Dis, G21,9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA
关键词
FECAL MICROBIOTA TRANSPLANTATION; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE EPIDEMIOLOGY; INTESTINAL MICROBIOME; DISEASES SOCIETY; VANCOMYCIN; BEZLOTOXUMAB; UPDATE; ADULTS; FIDAXOMICIN;
D O I
10.3949/ccjm.87gr.20001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clostridioides difficile infection (CDI) is the most common cause of diarrhea in hospitalized patients and results in substantial morbidity, mortality, and costs. Its clinical management, primarily with antibiotics, is often complicated by recurrent episodes. These recurrent CDI episodes are thought to be caused by antibiotic disruption of colonic microbiota and usually occur within 4 weeks of completing antibiotic therapy. The risk of recurrent CDI increases after the first episode, creating a need for management strategies to diagnose, treat, and prevent these complications.
引用
收藏
页码:347 / 359
页数:13
相关论文
共 50 条
  • [21] Prevention of Infection due to Clostridium (Clostridioides) difficile
    Krishna, Amar
    Chopra, Teena
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2021, 35 (04) : 995 - 1011
  • [22] Clostridioides difficile Infection: Update on Management
    Mounsey, Anne
    Smith, Kelly Lacy
    Reddy, Vinay C.
    Nickolich, Sarah
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (03) : 168 - 175
  • [23] Outcomes of Patients Receiving Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection - A Multicenter Study
    Chaar, Abdelkader
    Damianos, John
    Rizwan, Rabia
    Nawaz, Ahmad
    Feuerstadt, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S99 - S100
  • [24] Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
    Lam, Angela Y.
    Gutin, Liat S.
    Nguyen, Yume
    Velayos, Fernando S.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (11) : 3111 - 3115
  • [25] Infusion of Bezlotoxumab at the End of an Antibiotic Treatment Course for Prevention of Recurrent Clostridioides difficile Infection
    Westman, Colin
    Birris, Thomas
    Skinner, Andrew M.
    Johnson, Stuart
    Wang, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S82 - S82
  • [26] Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
    Angela Y. Lam
    Liat S. Gutin
    Yume Nguyen
    Fernando S. Velayos
    Digestive Diseases and Sciences, 2020, 65 : 3111 - 3115
  • [27] Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
    Tariq, Raseen
    Saha, Srishti
    Solanky, Dipesh
    Pardi, Darrell S.
    Khanna, Sahil
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (06) : 542 - 547
  • [28] Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection
    Bloom, Patricia P.
    Young, Vincent B.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 89 - 101
  • [29] Efficacy and Safety of Monoclonal Antibodies Against Clostridioides difficile Toxins for Prevention of Recurrent Clostridioides difficile Infection A Systematic Review and Meta-Analysis
    Akiyama, Shintaro
    Yamada, Akihiro
    Komaki, Yuga
    Komaki, Fukiko
    Micic, Dejan
    Sakuraba, Atsushi
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (01) : 43 - 51
  • [30] Fecal microbiota transplantation for recurrent Clostridioides difficile infection
    Haber, Stacy L.
    Raney, Carrington R. K.
    Larson, Trent L.
    Lau, Jennifer Park
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (13) : 935 - 942